drugset / Trial / NCT02487082

Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders

NCT02487082

Phase 2 Terminated 12 enrolled Stony Brook University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test the combined effect of melatonin and donepezil on improving sleep and behavior in children with Autism Spectrum Disorders. Melatonin is a natural neurohormone that helps regulate sleep and wake cycles. Donepezil is used to improve mental function for people with Alzheimer's disease. Children with Autism Spectrum Disorders are more likely to have problems sleeping than other children. This difficulty has been linked to daytime behavioral problems and family stress.

Timeline

Start
2015-06
Primary completion
2020-12-31
Completion
2021-01-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 2.5 mg
Subject Donepezil Small molecule 5 mg
Subject Melatonin Small molecule 3 mg